GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Nuveen Multi-Market Income Fund (NYSE:JMM) » Definitions » Sloan Ratio %

Nuveen Multi-Marketome Fund (Nuveen Multi-Marketome Fund) Sloan Ratio % : 0.00% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Nuveen Multi-Marketome Fund Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Nuveen Multi-Marketome Fund's Sloan Ratio for the quarter that ended in Dec. 2023 was 0.00%.

As of Dec. 2023, Nuveen Multi-Marketome Fund has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Nuveen Multi-Marketome Fund Sloan Ratio % Historical Data

The historical data trend for Nuveen Multi-Marketome Fund's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuveen Multi-Marketome Fund Sloan Ratio % Chart

Nuveen Multi-Marketome Fund Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Sloan Ratio %
Get a 7-Day Free Trial - - - - -

Nuveen Multi-Marketome Fund Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Nuveen Multi-Marketome Fund's Sloan Ratio %

For the Asset Management subindustry, Nuveen Multi-Marketome Fund's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nuveen Multi-Marketome Fund's Sloan Ratio % Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Nuveen Multi-Marketome Fund's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Nuveen Multi-Marketome Fund's Sloan Ratio % falls into.



Nuveen Multi-Marketome Fund Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Nuveen Multi-Marketome Fund's Sloan Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Sloan Ratio=(Net Income (A: Jun. 2023 )-Cash Flow from Operations (A: Jun. 2023 )
-Cash Flow from Investing (A: Jun. 2023 ))/Total Assets (A: Jun. 2023 )
=(1.567-1.628
-0)/87.021
=-0.07%

Nuveen Multi-Marketome Fund's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2023 )
=(4.464-4.569
-0)/86.826
=-0.12%

For company reported semi-annually, GuruFocus uses latest two semi-annual data as the TTM data. Nuveen Multi-Marketome Fund's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was 1.877 (Jun. 2023 ) + 2.587 (Dec. 2023 ) = $4.46 Mil.
Nuveen Multi-Marketome Fund's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was 1.75 (Jun. 2023 ) + 2.819 (Dec. 2023 ) = $4.57 Mil.
Nuveen Multi-Marketome Fund's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was 0 (Jun. 2023 ) + 0 (Dec. 2023 ) = $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuveen Multi-Marketome Fund  (NYSE:JMM) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, Nuveen Multi-Marketome Fund has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Nuveen Multi-Marketome Fund Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Nuveen Multi-Marketome Fund's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuveen Multi-Marketome Fund (Nuveen Multi-Marketome Fund) Business Description

Traded in Other Exchanges
N/A
Address
333 West Wacker Drive, Chicago, IL, USA, 60606
Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund seeks to invest in debt securities, including, but not limited to, U.S. agency and privately issued mortgage-backed securities, corporate debt securities, and asset-backed securities.
Executives
Trey Iii Stenersen officer: Vice President 333 WEST WACKER DRIVE, C/O NUVEEN STE 3400, CHICAGO IL 60606
Brett Black officer: Chief Compliance Officer 333 WEST WACKER DRIVE, C/O NUVEEN STE 3400, CHICAGO IL 60606
John M. Mccann officer: Vice President 333 WEST WACKER DRIVE, C/O NUVEEN STE 3400, CHICAGO IL 60606
Joanne Medero director 333 W. WACKER DRIVE, C/O NUVEEN, STE 3400, CHICAGO IL 60606
Lancellotta Amy B.r. other: Trustee 333 W. WACKER DRIVE, C/O NUVEEN, STE 3400, CHICAGO IL 60606
Matthew Iii Thornton other: Trustee 3610 HACKS CROSS ROAD, MEMPHIS TN 38125
Deann Morgan officer: Vice President TWO WORLD FINANCIAL CENTER, 7TH FLOOR, NEW YORK NY 10281
Jon Scott Meissner officer: Vice President 333 W WACKER DRIVE, STE 3400, CHICAGO IL 60606
Jacques M Longerstaey officer: Vice President 333 WEST WACKER DRIVE, C/O NUVEEN STE 3400, CHICAGO IL 60606
Brian J Lockhart officer: Vice President 333 WEST WACKER DRIVE, C/O NUVEEN STE 3400, CHICAGO IL 60606
E. Scott Wickerham officer: Vice President C/O NUVEEN, STE 3400, CHICAGO IL 60606
Huffman William T. Jr. officer: President of NAM, LLC C/O NUVEEN INVESTMENTS, 333 W. WACKER DRIVE, STE. 3300, CHICAGO IL 60606
Demark L Winget officer: Vice President C/O NUVEEN INVESTMENTS, 333 W WACKER DRIVE, CHICAGO IL 60606
William T. Meyers officer: Vice President C/O NUVEEN, 333 W. WACKER DRIVE, CHICAGO IL 60606
Michael A Perry officer: Vice President 101 PARK AVENUE, SUITE 1400, OKLAHOMA CITY OK 73102

Nuveen Multi-Marketome Fund (Nuveen Multi-Marketome Fund) Headlines

No Headlines